The roles of ncRNAs and histone-modifiers in regulating breast cancer stem cells |
| |
Authors: | Zhiju Zhao Shu Li Erwei Song Suling Liu |
| |
Affiliation: | 1. Innovation Center for Cell Signalling and the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of LifeSciences and Medical Center, University of Science & Technology of China, Hefei 230027, China2. Department of Pathophysiology, Wannan Medical College, Wuhu 241002, China3. Department of Breast Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China |
| |
Abstract: | Cancer stem cells (CSCs), a subpopulation of cancer cells with ability of initiating tumorigenesis, exist in many kinds of tumors including breast cancer. Cancer stem cells contribute to treatment resistance and relapse. Conventional treatments only kill differentiated cancer cells, but spare CSCs. Combining conventional treatments with therapeutic drugs targeting to CSCs will eradicate cancer cells more efficiently. Studying the molecular mechanisms of CSCs regulation is essential for developing new therapeutic strategies. Growing evidences showed CSCs are regulated by non-coding RNA (ncRNA) including microRNAs and long non-coding RNAs (lncRNAs), and histone-modifiers, such as let-7, miR-93, miR-100, HOTAIR, Bmi-1 and EZH2. Herein we review the roles of microRNAs, lncRNAs and histonemodifiers especially Polycomb family proteins in regulating breast cancer stem cells (BCSCs). |
| |
Keywords: | breast cancer stem cells microRNA lncRNA histone-modifier Polycomb group proteins |
|
| 点击此处可从《蛋白质与细胞》浏览原始摘要信息 |
|
点击此处可从《蛋白质与细胞》下载全文 |
|